Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-19 · accession 0001104659-25-015734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-19 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $38.18 | -5,359 | 540.3K | -1.0% | -$204.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | S | D | 5,359 | $38.18 | 540,260 | D | — | — | (F1) Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. |